This coming November, voters in North Dakota will have the chance to decide on whether to legalize cannabis at the ballot. The office of the Secretary of State, Al Jaeger, approved the initiative earlier this week, certifying that all requirements to put the proposal before voters had been met.

Activists began to collect signatures for the measure, dubbed New Approach ND, in April. In total, the group collected more than 26,000 submissions, which was more than was required. The initiative’s provisions are similar to the House-approved legalization measure that was rejected by the Senate.

This measure will allow individuals aged 21 and above in the state to buy and possess up to four grams of cannabis concentrate and an ounce of marijuana. They will also be allowed to grow no more than three cannabis plants for personal use.

Upon the measure’s approval, the Health and Human Services department or any other designated agency by the measure will be in charge of licensing for marijuana businesses and developing rules for the program. Regulators will have until October 2023 to develop rules related to labeling, packaging, testing, advertising and security standards.

The measure also stipulates that no entity or individual will be permitted to own 4 retail locations or more than a single cultivation facility. This is in an effort to reduce the risk of the market being monopolized by large firms. It also highlights that the department can only license a maximum of eighteen retailers and 7 cultivation facilities.

However, the measure does not specify any child custody protections for parents who use marijuana in compliance with state law. Employers will also not be prohibited from enforcing existing drug policies that forbid the use of cannabis.

While the state’s 5% sales tax will apply to marijuana products, no additional tax will be imposed on cannabis specifically. Additionally, local jurisdictions will still be able to prohibit cannabis businesses from operating in their area, with marijuana firms being required to follow local zoning rules.

It should be noted that the public consumption of cannabis will remain prohibited once the measure is approved. Furthermore, the measure will not provide a pathway for individuals with past criminal records to expunge any convictions related to marijuana. Activists have revealed that they plan to work with legislators to enact a separate initiative that will address the expungement issue next year.

The legalization measure will be designated on the ballot as Measure 1.

Depending on what the voters decide, yet another market could give established companies such as American Cannabis Partners an extra state in which to consider expanding into in the not so distant future.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

In the recent past, we have seen the rapid increase in personal wellness products and growing public health concerns create more proactive and health-conscious consumers. New market research shows that 70% of consumers purchase certain food products that have functional benefits to support their physical and mental well-being.

As more individuals begin prioritizing their health, the marijuana industry is afforded the opportunity to develop formulations that cater to these varied and evolving consumer preferences. Brands involved in the space can now create products that showcase the plant’s numerous applications by harnessing the power of minor cannabinoids and less popular terpenes instead of remaining focused on how they can continue developing more CBD and THC products.

Below are some ways players in the industry can drive innovation within the space and allow for more scientific studies on the plant’s benefits to be conducted.

Creating products to help with sleeping issues

At the moment, millennials make up the biggest share of marijuana consumers in America. This group often struggles with sleep disorders and experiences high levels of stress, which explains why they use sleep aids more than their gen X and baby boomer counterparts.

When developing new products, players in the industry may benefit from paying close attention to this type of information as well as other lifestyle habits of this group. Brands may formulate products that have been designed to optimize sleep. For instance, CBG and CBN can be paired with terpenes such as linalool and nerolidol to help consumers rest.

Creating products that allow for healthy decompressing

After a long day, many individuals like to unwind and relax. Infusion technology can be used to create cannabis drinks that are not only healthy but also afford their consumers euphoric and relaxing experiences.

Brands may use terpenes such as limonene and myrcene to create such experiences through their products, which will help drive consumption and address growing consumer demand.

Creating products that enhance an individual’s performance

Consumers in the market also seek products that enhance their physical and mental performance, which can explain the increasing demand for energy drinks. Recent research has found that minor cannabinoids such as THCv can enhance energy metabolism while terpenes such as pinene, limonene and beta-caryophyllene can improve focus. This is in addition to improving cognitive function and increasing energy.

Focusing on the creation of beverages with such compounds may benefit both companies and consumers, especially as more consumers consume less sugar-sweetened drinks.

Companies in this space, such as Prime Harvest Inc., can choose from a variety of different aspects upon which to focus their innovative efforts, and the combination of the different licensed companies working to push the envelope may result in an advanced marijuana industry in the long run.

NOTE TO INVESTORS: The latest news and updates relating to Prime Harvest Inc. are available in the company’s newsroom at https://cnw.fm/PRIME

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

As the coronavirus pandemic raged on, infecting millions of people across the world and taking thousands of lives each day, there were claims that cannabis use could potentially reduce the risk of contracting the virus. Looking to ascertain whether these claims were factual, researchers began looking at the relationship between cannabis and COVID-19 and found that the controversial drug could indeed reduce the risk of developing coronavirus health complications.

Researchers have now found a link between marijuana consumption and reduced coronavirus severity among patients who were hospitalized due to COVID-19 complications. They say that cannabis could potentially lower the severity of the virus and result in better health outcomes. This is despite the fact that cannabis users involved in the study were five times more likely to use tobacco compared to nonusers.

The study, which involved 1,831 hospitalized patients who had COVID-19, found that cannabis users who were admitted with the coronavirus had a reduced need for mechanical ventilation and ICU admission. It was published in the “Journal of Cannabis Research.” In the report, 4% (69) of the study participants reported using cannabis regularly, with the active cannabis users being younger, less often diabetic, and having higher tobacco smoking rates.

Researchers also found that active cannabis users had fewer inflammatory markers when they were admitted compared to COVID-19 patients who did not use cannabis. They had lower levels of C-reactive protein (CRP), ferritin, D-dimer and procalcitonin compared to nonusers. Furthermore, cannabis users had better health outcomes after infection compared to nonusers, ultimately exhibiting a reduced need for mechanical ventilation (6% vs. 17% in nonusers), lower ICU admission rates (12% vs. 31%) and shorter hospitalization intervals (four days vs. six days).

Study authors believe the better health outcomes associated with regular cannabis use for COVID-19 patients could be due to the medical properties of cannabinoids. Produced by cannabis plants, cannabinoids have been found to have a variety of medical benefits because of their potent anti-inflammatory, antioxidant and antimicrobial properties.

The study said that intubation rates were 6 percentage points lower and ICU admission was 12 percentage points lower in active cannabis users. The researchers concluded that based on their study, it seemed that cannabis users who were admitted with COVID-19 had better clinical outcomes compared to nonusers.

However, the researchers acknowledged that their study had plenty of limitations because it was a retrospective analysis and encouraged interested parties to interpret the results with caution. They called for future observational and prospective studies to get a better idea of how cannabis use can affect COVID-19 patients.

More research is needed to clarify which conditions marijuana may help with so that consumers can be certain that, as they consume the products made by entities such as American Cannabis Partners either recreationally or medically, they can expect to enjoy a given set of benefits based on the compounds present in the specific product they are consuming.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 50+ brands within IBN (“InvestorBrandNetwork”), today announced its reengagement by GIE Media to serve as a media sponsor for Cannabis Conference 2022. The unique event, presented by Cannabis Business Times, is slated to take place at the Paris Las Vegas Hotel & Casino in Las Vegas, Nevada, from Aug. 23-25, 2022. Industry participants from more than 30 countries will attend the globally acclaimed conference, which is dedicated to professionals of plant-touching businesses across the cannabis and hemp space. IBN and CannabisNewsWire will leverage their array of extensive corporate communications solutions to heighten recognition for conference participants seeking to enhance visibility among investors, journalists, consumers and the broader public. “GIE Media is a highly professional organization with a wonderful team. The Cannabis Conference is a one-of-a-kind event, and we are very pleased to continue our collaboration with GIE as an official media sponsor,” said Cami Cox, director of analytics and reporting for CannabisNewsWire. “This conference is a stand-out event that provides top-class educational opportunities to industry participants, facilitates networking and showcases the very best in technical advancements.”

To view the full press release, visit https://cnw.fm/gP9LH

About CannabisNewsWire (“CNW”)

CannabisNewsWire, one of 50+ brands within the InvestorBrandNetwork (“IBN”), is a specialized information service that (1) aggregates cannabis news; (2) provides CannabisNewsBreaks to quickly update investors in the space; (3) enhances corporate press releases; (4) provides social media distribution via IBN to millions of social media followers; and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of 5,000+ key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.

For more information, please visit www.CannabisNewsWire.com.

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The NECANN Conference has evolved into the largest conference on the East Coast, attracting cannabis cultivators, traders, regulators, lawmakers, and enthusiasts, from the East Coast and beyond. The 3rd annual New Jersey Cannabis Convention is being held from September 9-10, 2022, in Atlantic City, New Jersey.

This is a well-curated event organized by a highly talented team of professionals with desired expertise and experience. They keep in mind the needs and requirements of the cannabis community and bring together investors, young and veteran cannabis and hemp traders, as well as researchers and lawmakers, all in a common forum.

After fighting a tough battle for legalizing both medicinal and recreational cannabis, New Jersey, on February 22nd, 2021, became the fourteenth U.S. state to legalize marijuana completely. Atlantic City has a huge cannabis market waiting to get discovered and tapped by marijuana traders and customers. Also, the city has very limited cannabis dispensary availability to cater to the entire population. The NECANN exhibition will bring the New Jersey cannabis community to the forefront to get discovered by potential investors.

The 3rd annual NJ NECANN event will witness an important lineup of speakers and industry veterans. They will share useful insights about the latest industry trends and discuss important issues covering the entire range of topics under the cannabis spectrum. Exhibitors can set up their respective booths to pitch their businesses. The 3rd Annual NJ Cannabis Convention will be a one-of-its-kind experience, to discover more cannabis communities and exchange ideas and information about marijuana businesses.

The NECANN team brings in cannabis trade investors and entrepreneurs who are interested in novel and fresh business ideas. Budding entities can leverage the reach of the NECANN platform to gain visibility among potential investors. Established in 2014, NECANN events are one of the largest cannabis conventions offering mammoth networking opportunities. The NECANN events attract Hemp, MMJ, and Cannabis industry professionals, to meet and build critical long-term business ties.

The NECANN convention offers a robust platform for local cannabis businesses to showcase their products and services. It allows them to meet the stalwarts of the cannabis community and attract lucrative investments into the developing New Jersey cannabis market. Overall, the event represents a unique opportunity to get in on the ground floor.

The NECANN team works tirelessly to cover every aspect of the cannabis industry ranging from inventory, legal issues, packaging, insurance, regulations, security, from testing to cultivation, marketing, and more.

To learn more, please visit https://cnw.fm/uJif3

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.